Aeglea BioTherapeutics
SERVICES PROVIDED:
- Strategic Positioning
- Identity Design
- Campaign Development
- Website Design & Development
- Social Media Channel Design
Design Partner: Spirolab
Aeglea BioTherapeutics is a clinical-stage company developing human enzyme therapeutics to help people battling rare and devastating metabolic diseases with limited treatment options.
22 Fillmore teamed with Aeglea to fine tune its positioning and brand identity as the company prepares for the potential commercialization of its lead Phase 3 clinical asset.
The scope of work consisted of refining the brand strategy, redesigning the corporate logo and identity system, developing a new creative positioning campaign and overhauling the website.
The Aeglea corporate website was selected as the “Best Biotechnology Website” by the Web Marketing Association as part of the 2021 WebAward Competition.
Aeglea was acquired by Spyre Therapeutics in 2023.
